Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Gastroenterology | Infections and Infectious Diseases
Search Medical Condition
Infectious Colitis Clinical Trials
A listing of Infectious Colitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (13) clinical trials
Crohn's Disease
A study to evaluate the safety and efficacy of an investigational drug in subjects with moderate to severe Crohn's disease. REF: 001-CGI
A Phase 3 Clinical Trial for Patients with Moderately to Severely Active Ulcerative Colitis
To assess the effect of vedolizumab SC maintenance treatment on clinical remission at Week 52 in subjects with moderately to severely active UC who achieved clinical response at Week 6 following administration of vedolizumab IV at Weeks 0 and 2.
Medical research study for people with Moderately to Severely Active Ulcerative Colitis
Winthrop University Hospital’s Clinical Trials Center is seeking volunteers with moderately to severely active Ulcerative Colitis. The main purpose of this study is to see if an investigational medication is useful and safe for treating patients with moderately to severely active ulcerative colitis. Eligible participants will receive study-related medication and ...
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Ulcerative Colitis.
This study is designed to evaluate the effect of treatment with filgotinib on testicular safety in adult males with moderately to severely active Ulcerative Colitis (UC). Stipend range: $75o/v, $100proc For those patients who complete the trial, they will be eligible for the long-term extension study, for up to 195 ...
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06687234 as Add-On Therapy to Infliximab in Active Ulcerative Colitis Subjects Who Are Not in Remission
This is a phase 2a, randomized, double-blind, placebo-controlled, parallel group, multicenter study in subjects with active UC and a non-remission response to infliximab. There will be up to 13 study visits, across the 12 weeks of treatment, along with 2 follow-up visits, at Weeks 16 and 22. Ideal patients ...
A Phase 4 Open-Label Study to Evaluate Vedolizumab IV Dose Optimization on Treatment Outcomes in Non-Responders with Moderately to Severely Active Ulcerative Colitis (ENTERPRET)
This is a phase 4, open-label, multicenter study to investigate the efficacy and safety of dose optimization of vedolizumab IV, compared with standard dosing of vedolizumab IV, over a 30-week treatment period. This study will enroll adult subjects with moderately to severely active ulcerative colitis (UC) who are eligible for ...
Combined Phase 2B / 3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis
This study is designed to evaluate the effect of treatment with filgotinib on the induction and maintenance of remission in subjects with moderately to severely active Ulcerative Colitis (UC). For those patients who complete the trial, they will be eligible for the long-term extension study, for up to 144 additional ...
Combined Phase 3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn's Disease
This study is designed to evaluate the effect of treatment with filgotinib on the induction and maintenance of remission in subjects with moderately to severely active Crohn's disease (CD).
Observational, Real-World Study of Inflectra in Patients with IBD
This is a prospective, observational, multicenter study conducted in adult patients with UC or CD; this study plans to recruit subjects in the United States initiating treatment with or switching to INFLECTRA. There will be a total of 4 study visits, at 3, 6, 9, and 12 months. Each visit ...
Phenomics in Autoimmune and Inflammatory Diseases
The family of inflammatory/autoimmune systemic diseases (IAD) represents a large group of human diseases. For most if not all of these IAD, the pathophysiological processes or exact causes remain poorly understood. Progresses in molecular understanding of these IAD have led to realize that these are not two distinct categories of ...
